Scarica l'app Stockscreener
10.16
0.89%
0.09
Precedente Chiudi:
$10.07
Aprire:
$9.94
Volume 24 ore:
78,403
Relative Volume:
0.28
Capitalizzazione di mercato:
$388.31M
Reddito:
$239.40M
Utile/perdita netta:
$104.44M
Rapporto P/E:
3.4324
EPS:
2.96
Flusso di cassa netto:
$-18.50M
1 W Prestazione:
+0.79%
1M Prestazione:
+53.47%
6M Prestazione:
+28.12%
1 anno Prestazione:
-49.10%
Intervallo 1D:
$9.52
$10.38
Intervallo di 1 settimana:
$9.40
$10.38
Portata 52W:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Nome
Entrada Therapeutics Inc
Settore
Industria
Telefono
857-305-1825
Indirizzo
ONE DESIGN CENTER PLACE, BOSTON
Confronta TRDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
10.16 | 384.87M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
| 2024-01-05 | Iniziato | Oppenheimer | Outperform |
| 2023-04-03 | Iniziato | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Borsa (TRDA) Ultime notizie
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Entrada Therapeutics Reports Third Quarter 2025 Financial Results - ADVFN
Brokerages Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Price Target at $20.67 - Defense World
Baker Bros. Advisors LP Increases Stake in Entrada Therapeutics Inc. - GuruFocus
Major Investment Alert: Baker Bros. Advisors Boosts Stake in Entrada Therapeutics! - TipRanks
Insider Sell: Kory Wentworth Sells Shares of Entrada Therapeutics Inc (TRDA) - GuruFocus
Entrada Therapeutics CFO Sells Shares Under Trading Plan - TradingView
CFO Wentworth Sells 8,910 ($88.9K) Of Entrada Therapeutics Inc [TRDA] - TradingView
[Form 4] Entrada Therapeutics, Inc. Insider Trading Activity - Stock Titan
CFO Wentworth Files To Sell 8,910 Of Entrada Therapeutics Inc [TRDA] - TradingView
Will Entrada Therapeutics Inc. stock deliver shareholder valueWeekly Loss Report & Daily Momentum Trading Reports - newser.com
Entrada Therapeutics (TRDA) Price Target Decreased by 10.81% to 16.83 - MSN
Why Entrada Therapeutics Inc. stock is favored by pension fundsTrade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com
(TRDA) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Questex’s Fierce Life Sciences Announces 2025 Innovation Awards Winners - GlobeNewswire Inc.
How risky is Entrada Therapeutics Inc. stock now2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Can Entrada Therapeutics Inc. stock resist market sell offs2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
Major Stock Sell-Offs at Entrada Therapeutics Inc! - TipRanks
Applying big data sentiment scoring on Entrada Therapeutics Inc.2025 Top Decliners & Consistent Return Investment Signals - newser.com
Owner 5AM Ventures V LP Sells 200,000 ($1.8M) Of Entrada Therapeutics Inc [TRDA] - TradingView
Chmn Parmar Sells 200,000 ($1.8M) Of Entrada Therapeutics Inc [TRDA] - TradingView
Is Entrada Therapeutics Inc a good long term investmentEarnings Growth Projections & Real-Life Case Studies You Can Follow - earlytimes.in
Real time pattern detection on Entrada Therapeutics Inc. stockWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha
Published on: 2025-11-16 13:38:00 - newser.com
Multi factor analysis applied to Entrada Therapeutics Inc.July 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
Is Entrada Therapeutics Inc. forming a bottoming basePortfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com
How Entrada Therapeutics Inc. stock benefits from strong dollarJuly 2025 Action & Verified Swing Trading Watchlist - newser.com
Published on: 2025-11-19 18:26:53 - newser.com
Owner 5AM Ventures V LP Files To Sell 200,000 Of Entrada Therapeutics Inc [TRDA] - TradingView
Entrada Therapeutics Eyes 2026 Trial Data With Cash Runway Into 2027 - RTTNews
Published on: 2025-11-13 23:16:53 - newser.com
Will Entrada Therapeutics Inc. stock gain from strong economyForecast Cut & AI Forecast Swing Trade Picks - newser.com
Understanding Entrada Therapeutics Inc.’s price movement2025 EndofYear Setup & Community Consensus Trade Alerts - newser.com
Does Entrada Therapeutics Inc. stock trade at a discount to peersJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Entrada Therapeutics Inc Azioni (TRDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):